Eunjung Han

Eunjung Han

Auto-generated profile, based on publicly available information

Eunjung Han

Department of Otorhinolaryngology‐Head and Neck Surgery Korea University Ansan Hospital Ansan Gyeonggi Republic of Korea

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2022 in Hearing Research
Verified
Journal Article
Closed access
EHEunjung Han
Eunjung Han
DLDae Hyeok Lee
Dae Hyeok Lee
SPSaemi Park
Saemi Park
YRYoon Chan Rah
Yoon Chan Rah
HPHae-Chul Park
Hae-Chul Park
JCJune Choi
June Choi

1 January 2006
Verified
Book Chapter
Closed access
PDF file
YLYun Li Lee
Yun Li Lee
DKDongwuk Kyoung
Dongwuk Kyoung
EHEunjung Han
Eunjung Han
KJKeechul Jung
Keechul Jung

30 November 2024 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
HBHyun woo Baek
Hyun woo Baek
EHEunjung Han
Eunjung Han
KOKyoung Ho Oh
Kyoung Ho Oh
Objectives. Our study aimed to explore the role of the potassium channel KCNK1 in head and neck squamous cell carcinoma, focusing on its impact on tumor growth, invasion, and metastasis. We also investigated the therapeutic potential of quinidine, a known KCNK1 inhibitor, in both in vitro cell lines and a zebrafish patient-derived xenograft (PDX) model.Methods. We established primary cell cultures from head and neck cancer tissues and employed the FaDu cell line for in vitro studies, modulating KCNK1 expression through overexpression and knockdown techniques. We evaluated cell migration, invasion, and proliferation. Additionally, we developed a zebrafish PDX model to assess the impact of quinidine on tumor growth and metastasis in vivo. RNA sequencing and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were conducted to elucidate the molecular mechanisms underlying the role of KCNK1 in cancer progression.Results. Overexpression of KCNK1 in FaDu cells resulted in enhanced cell migration and invasion, whereas its knockdown diminished these processes. In the zebrafish PDX model, quinidine markedly inhibited tumor growth and metastasis, demonstrating a significant reduction in tumor volume and micrometastasis rates compared to the control groups. The molecular analyses indicated that KCNK1 plays a role in critical signaling pathways associated with tumor growth, such as the Ras and MAPK pathways.Conclusion. Our findings highlight the critical role of KCNK1 in promoting tumor growth and metastasis in head and neck cancer. The inhibitory effect of quinidine on tumor progression in the zebrafish PDX model highlights the therapeutic potential of targeting KCNK1. These results suggest that KCNK1 could serve as a valuable therapeutic target for head and neck cancer, warranting further investigation into treatments that target KCNK1.

23 December 2025 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
HBHyun woo Baek
Hyun woo Baek
SPSaemi Park
Saemi Park
YKYeonhwa Kim
Yeonhwa Kim
KHKyungtae Hyun
Kyungtae Hyun
SHSumin Hong
Sumin Hong
JCJune Choi
June Choi